Onyx embolization of intracranial arteriovenous malformations in pediatric patients

Clinical article

Restricted access

Object

The authors undertook this study to assess the safety and efficacy of Onyx embolization in the treatment of intracranial arteriovenous malformations (AVMs) in pediatric patients.

Methods

All pediatric Onyx embolization of intracranial AVM cases performed consecutively at a single children's hospital over a 5-year period were collected and evaluated.

Results

Twenty-five patients (mean age 10.5 years) underwent a total of 38 procedures. An aggregate of 56 pedicles were embolized (mean 1.47 per session). The Spetzler-Martin grade was determined in all cases. Onyx embolization resulted in complete obliteration of the AVM in 3 cases (12%) and partial obliteration in 22 cases (88%). A total of 23 patients underwent surgical treatment. The mean preoperative AVM devascularization in these cases was 72%. One patient was treated with radiosurgery following Onyx embolization. Overall, 10 complications occurred in a total of 38 procedures (26.3%). None of the complications resulted in permanent neurological morbidity. The rate of transient neurological complications was 10.5% (4 of 38 procedures) and the rate of transient nonneurological complications was 5.3% (2 of 38 procedures). The remaining 4 complications were clinically silent (rate of 10.5%). There were no procedure-related deaths in this study population. There was no significant difference in patients with and without complications in terms of demographic characteristics, AVM grade, or embolization features (p ≥ 0.2). Deep venous drainage was associated with higher complication rates (p = 0.03).

Conclusions

Onyx utilization is feasible for preoperative or primary embolization in the treatment of pediatric intracranial AVMs; however, the spectrum of complications encountered is broad, and attention must be paid to the technical nuances of and indications for its use to avoid many potential dangerous effects. Although the overall complication rates were higher than expected, all were either clinically silent or had only transient clinical effects. Thus, this experience suggests that Onyx embolization can be performed safely with a low rate of permanent morbidity in pediatric patients harboring these difficult lesions.

Abbreviations used in this paper:AVM = arteriovenous malformation; DAVF = dural arteriovenous fistula; DMSO = dimethyl sulfoxide; HIPAA = Health Insurance Portability and Accountability Act; mRS = modified Rankin Scale; n-BCA = n-butyl cyanoacrylate; PACS = picture archiving and communication system; PICU = pediatric intensive care unit.

Article Information

Address correspondence to: Ali Shaibani, M.D., Northwestern University Feinberg School of Medicine, 676 North St. Clair Street, Suite 800, Chicago, Illinois 60611. email: ashaibani@nch.org.

Please include this information when citing this paper: published online February 8, 2013; DOI: 10.3171/2013.1.PEDS12286.

© AANS, except where prohibited by US copyright law.

Headings

References

  • 1

    Akin EDPerkins ERoss IB: Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine. J Neurosurg 98:3663702003

  • 2

    Ansell GTweedie MCWest CREvans PCouch L: The current status of reactions to intravenous contrast media. Invest Radiol 15:6 SupplS32S391980

  • 3

    Bristol REAlbuquerque FCSpetzler RFRekate HLMcDougall CGZabramski JM: Surgical management of arteriovenous malformations in children. J Neurosurg 105:2 Suppl88932006

  • 4

    Celli PFerrante LPalma LCavedon G: Cerebral arteriovenous malformations in children. Clinical features and outcome of treatment in children and in adults. Surg Neurol 22:43491984

  • 5

    Cronqvist MWirestam RRamgren BBrandt LRomner BNilsson O: Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging. AJNR Am J Neuroradiol 27:1621762006

  • 6

    Eddleman CSSurdell DDiPatri A JrTomita TShaibani A: Infectious intracranial aneurysms in the pediatric population: endovascular treatment with Onyx. Childs Nerv Syst 24:9099152008

  • 7

    Germanwala AVVora NAThomas AJJovin TGologorsky YHorowitz MB: Ethylenevinylalcohol copolymer (Onyx-18) used in endovascular treatment of vein of Galen malformation. Childs Nerv Syst 24:1351382008

  • 8

    Herman TESiegel MJVachharajani AMasand PCross D: Cerebral arteriovenous fistula to pulmonary artery onyx embolization. J Perinatol 27:2382402007

  • 9

    Jankowitz BTVora NJovin THorowitz M: Treatment of pediatric intracranial vascular malformations using Onyx-18. J Neurosurg Pediatr 2:1711762008

  • 10

    Jayaraman MVMarcellus MLHamilton SDo HMCampbell DChang SD: Neurologic complications of arteriovenous malformation embolization using liquid embolic agents. AJNR Am J Neuroradiol 29:2422462008

  • 11

    Liu LJiang CHe HLi YWu Z: Periprocedural bleeding complications of brain AVM embolization with Onyx. Interv Neuroradiol 16:47572010

  • 12

    Loh YDuckwiler GR: A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 113:7337412010

  • 13

    Lv XJiang CZhang JLi YWu Z: Complications related to percutaneous transarterial embolization of intracranial dural arteriovenous fistulas in 40 patients. AJNR Am J Neuroradiol 30:4624682009

  • 14

    Maimon SStrauss IFrolov VMargalit NRam Z: Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results. AJNR Am J Neuroradiol 31:9479542010

  • 15

    Morcos SK: Review article: Effects of radiographic contrast media on the lung. Br J Radiol 76:2902952003

  • 16

    Murugesan CSaravanan SRajkumar JPrasad JBanakal SMuralidhar K: Severe pulmonary oedema following therapeutic embolization with Onyx for cerebral arteriovenous malformation. Neuroradiology 50:4394422008

  • 17

    Panagiotopoulos VGizewski EAsgari SRegel JForsting MWanke I: Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:991062009

  • 18

    Sanchez-Mejia ROChennupati SKGupta NFullerton HYoung WLLawton MT: Superior outcomes in children compared with adults after microsurgical resection of brain arteriovenous malformations. J Neurosurg 105:2 Suppl82872006

  • 19

    Santos NCFigueira-Coelho JMartins-Silva JSaldanha C: Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65:103510412003

  • 20

    Smith ERButler WEOgilvy CS: Surgical approaches to vascular anomalies of the child's brain. Curr Opin Neurol 15:1651712002

  • 21

    Spetzler RFMartin NA: A proposed grading system for arteriovenous malformations. J Neurosurg 65:4764831986

  • 22

    Thiex RWilliams ASmith EScott RMOrbach DB: The use of Onyx for embolization of central nervous system arteriovenous lesions in pediatric patients. AJNR Am J Neuroradiol 31:1121202010

  • 23

    van Rooij WJSluzewski MBeute GN: Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28:1721782007

  • 24

    Weber WKis BSiekmann RJans PLaumer RKühne D: Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 61:2442542007

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 145 145 15
Full Text Views 105 105 3
PDF Downloads 74 74 0
EPUB Downloads 0 0 0

PubMed

Google Scholar